Modeling and Reconstruction of Mixed Functional
and Molecular Patterns by Wang, Yue et al.
Hindawi Publishing Corporation
International Journal of Biomedical Imaging
Volume 2006, Article ID 29707, Pages 1–9
DOI 10.1155/IJBI/2006/29707
Modeling and Reconstruction of Mixed Functional
and Molecular Patterns
Yue Wang,1 Jianhua Xuan,2 Rujirutana Srikanchana,3 and Peter L. Choyke4
1Department of Electrical and Computer Engineering, Computational Bioinformatics and Bioimaging Laboratory,
Virginia Polytechnic Institute and State University, 4300 Wilson Boulevard, Suite 750, Arlington, VA 22203, USA
2Department of Electrical Engineering and Computer Science, The Catholic University of America, Washington, DC 20064, USA
3Riverain Medical, Riverain Research Group, Rockville, MD 20850, USA
4Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Received 10 August 2005; Accepted 23 October 2005
Recommended for Publication by Ming Jiang
Functional medical imaging promises powerful tools for the visualization and elucidation of important disease-causing biological
processes in living tissue. Recent research aims to dissect the distribution or expression of multiple biomarkers associated with
disease progression or response, where the signals often represent a composite of more than one distinct source independent of
spatial resolution. Formulating the task as a blind source separation or composite signal factorization problem, we report here
a statistically principled method for modeling and reconstruction of mixed functional or molecular patterns. The computational
algorithmisbasedonalatentvariablemodelwhoseparametersareestimatedusingclusteredcomponentanalysis.Wedemonstrate
the principle and performance of the approaches on the breast cancer data sets acquired by dynamic contrast-enhanced magnetic
resonance imaging.
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1. INTRODUCTION
Functional imagingtechnologies are providing researchers
and physicians with exciting new tools to study important
disease-causing biological processes in living tissue [1, 2].
Dynamic contrast-enhanced magnetic resonance imaging
(DCE-MRI) uses various molecular weight contrast agents
to assess tumor vascular permeability and quantify cellular
and molecular abnormalities in blood vessel walls [3]. DCE-
MRI can characterize vascular heterogeneity and elucidate
features that distinguish angiogenic blood vessels from their
normal counterparts, and has potential utility in assessing
the eﬃcacy of angiogenesis inhibitors in cancer treatment
[2–4].AlthoughDCE-MRIcanprovideameaningfulestima-
tion of vascular permeability when a tumor is homogeneous,
many malignant tumors show markedly heterogeneous ar-
eas of permeability and vascular endothelial growth factor
(VEGF) expression; thus the signal of each pixel often re-
ﬂects multiple microenvironments in a tumor representing
a complex summation of vascular permeability with various
diﬀusion rates [2, 3].
Several quantitative methods based on parametric com-
partment modeling (CM) have been developed to dissect the
spatial distribution of vascular heterogeneity associated with
tumor angiogenesis [3, 5, 6]. These methods estimate the
fundamental kinetics components (called factors) and the
associated factor weights (called factor images) [6–8]. Each
factor is interpreted as the time course of a compartment,
whereas each factor image is interpreted as local weights rep-
resenting the spatial distribution of vascular permeability
with diﬀerent diﬀusion rates [2, 9]. The parametric model
chosen may not ﬁt the data obtained, and each model makes
a number of assumptions that may not be valid for every
tissue or tumor type. The causes for modeling failures are
complex and often not well understood [6, 10]. Key rea-
sons include multiple tissue compartments, an incorrect ar-
terial input function, and numerical nonidentiﬁability of
the parametric model [3, 6, 9–11]. This motivates the con-
sideration of clustered component analysis (CCA) that can
be based on a ﬂexible compartment latent variable model
[12, 13]. The objective is to factorize the underlying an-
giogenic permeability distributions (APD) and time activity2 International Journal of Biomedical Imaging
curves (TAC) from dynamically mixed DCE-MRI image se-
quences [14, 15].
2. THEORY AND METHODS
We ﬁrst introduce a simple form of compartment latent vari-
able model for DCE-MRI. Without loss of generality, we
initially focus on the two-tissue compartment model shown
in Figure 1. The tracer characterization within a region of in-
terest can be approximated by a set of ﬁrst-order diﬀerential
equations [15]:
˙ cf(t) = k1fcp(t) − k2fcf(t),
˙ cs(t) = k1scp(t) − k2scs(t),
c(t) = cf(t)+cs(t)+cp(t),
(1)
where cf(t)a n dcs(t) are the tissue activity in the fast turn-
over and slow turnover pools, respectively, at time t; cp(t)i s
the tracer concentration in plasma (the input function); c(t)
is themeasuredtotaltissue activity;k1f and k1s aretheunidi-
rectional transport constants from plasma to tissue (perme-
abilityinml/min/g:spatiallyvarying);k2f andk2s aretherate
constants for eﬄux (diﬀusion in /min: spatially invariant) in
the fast ﬂow and slow ﬂow pools, respectively [5–7].
Mathematical consideration based on a latent variable
model suggests a simple method to convert temporal kinet-
ics (1) to spatial information [7]. Let x(i) = [x(i,t1),x(i,t2),
...,x(i,tL)]T be the observed tracer activities of pixel i mea-
sured at L time points. Now consider a source vector of spa-
tial permeability distributions k(i) = [kf(i),ks(i),kp(i)]T to-
getherwithanL×3mixingmatrixA(t)whichmapsthelatent
space into the data space: x(i) = A(t)k(i)
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
x
 
i,t1
 
x
 
i,t2
 
. . .
x
 
i,tL
 
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
=
⎡
⎢ ⎢ ⎢ ⎢ ⎢ ⎢ ⎣
af
 
t1
 
as
 
t1
 
ap
 
t1
 
af
 
t2
 
as
 
t2
 
ap
 
t2
 
. . .
. . .
. . .
af
 
tL
 
as
 
tL
 
ap
 
tL
 
⎤
⎥ ⎥ ⎥ ⎥ ⎥ ⎥ ⎦
⎡
⎢ ⎢ ⎣
kf(i)
ks(i)
kp(i)
⎤
⎥ ⎥ ⎦,( 2 )
where the TACs associated with diﬀerent APDs are
af(t) = cp(t) ⊗e
−k2f t,
as(t) = cp(t) ⊗e
−k2st,
ap(t) = cp(t),
(3)
and ⊗ denotes the convolution operation. Relationship (2)
describes how the observed multivariate data are generated
by a process of mixing the latent components, as illustrated
in Figure 2.
Since the APDs k(i) and TACs A(t) are both unknown,
whatweseekintheabovemodelisanalgorithmthatcanper-
form blind source separation to recover the source patterns
from their observed mixtures. Based on the realistic assump-
tion that the APDs are spatially heterogeneous (e.g., piece-
wise stationary with insigniﬁcant spatial overlap) [2, 3, 16],
CCA on x(i) over the time domain aims to perform a non-
parametric multivariate clustering of pixel TACs similarly to
the successful application in functional MRI analysis [13].
Intuitively, when there are only pure-volume pixels, a one-
to-one association between pixel TAC x(i,t) and one of the
source TACs aj(t) exists—except for a local scaling by kj(i)
and some additive statistical variation
x(i) = kj(i)aj +ε(i), j ∈{f,s, p},( 4 )
where ε(i) is the noise term being both temporally and spa-
tially white Gaussian distributed with zero mean and un-
known variance σ2
x(i) and aj = [aj(t1),aj(t2),...,aj(tL)]T
[13]. However, note that the forms of compartment TACs
in (4) are no longer necessarily parametric as in (3)a n da r e
much more ﬂexible; this should help reduce the potential for
modeling failures. To perform a top-down CCA on x(i)t o
estimate aj based on (4), the shape rather than the magni-
tude kj(i) of the pixel TAC is of the interest [7, 11, 17]. By
performing both “centering” and “normalization” over time,
given by
xn(i,t) =
1
σx(i)
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1
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,( 5 )
each pixel TAC can be transformed to a constant scale with
mean zero independent of amplitude variations, denoted by
the normalized xn(i). There has been considerable success in
using the standard ﬁnite normal mixture (SFNM) distribu-
tion to model clustered data sets, taking a sum of the follow-
ing general form [18]:
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whereπ isthemixingfactorandg istheGaussiankernelwith
mean aj and covariance matrix Cj.
Finding an estimate of the mixing matrix A comes down
to performing a maximum likelihood estimation of the
SFNM model (6), where the joint log-likelihood is given by
Φ
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where N is the number of the pixels. This clustered com-
ponent analysis task can be, fortunately, solved by the
expectation-maximization (EM) algorithm that maximizes
the joint log-likelihood [13, 15, 18]
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Figure 1: Schematic diagram of two-tissue compartment model and time-activity curves of fast and slow diﬀusions for quantifying tumor
vascular characteristics based on DCE-MRI. The patterns of interest include the heterogeneous spatial distribution of vascular permeability
associated with fast and slow diﬀusions.
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Figure 2: Illustration of source pattern mixing process.
wherethe“soft”splitsofapixelTACallowxn(i)tocontribute
simultaneously to multiple source TACs. Speciﬁcally, in or-
der to compute the expectation step of the EM algorithm, we
must ﬁrst estimate the posterior probability that each pixel
TAC xn(i)isofsour c eT A Caj,namely,themaximizationstep
of the EM algorithm [13]. Such estimated posterior Bayes
probabilities of pixel TAC xn(i) associated with one of the
source TACs are given by
zij = P
 
j | xn(i)
 
=
πjg
 
xn(i) | aj,Cj
 
p
 
xn(i)
  , j ∈{f,s, p} (9)
andthecompartmentTACsarethenormalizedandweighted
sample averages of pixel TACs in the light of their compart-
ment memberships estimated by (9), computed via the ex-
pectation step of the EM algorithm [13]:
aj =
 N
i=1zijxn(i)
 N
i=1zij
(10)
for j = f ,s, p. Having determined the mixing matrix A =
[af,as,ap] representing the compartment TACs, the APDs
canbereconstructedusingaleastsquaresﬁtaccordingto(2),
resulting in
  k(i) =
 
ATA
 −1ATx(i), (11)
where T denotes matrix transpose.
To perform CCA, we use the visual statistical data ana-
lyzer (VISDA) algorithm [18]. The main function of VISDA
is cluster modeling, discovery, and visualization. In addi-
tion to the multivariate soft clustering by the EM algorithm,
VISDA also includes model selection by minimum descrip-
tion length (MDL) criterion and cluster initialization by hi-
erarchical clustering. To capture all of the hidden clusters,
VISDA is both statistically principled and visually insight-
ful that incorporates both the power of statistical methods
and the human gift for pattern recognition. VISDA uses an
adaptive boosting of discriminatory subspaces involving hi-
erarchical mixture modeling, selected optimally by the MDL
criterion, and allows the complete data set to be visualized
at the top level and so partitions data set, with clusters and
subclusters of data points visualized at deeper levels.4 International Journal of Biomedical Imaging
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Figure 3: The estimated TACs derived from real DCE-MRI data by maximum likelihood method.
Complementary to (9)a n d( 10), the M step in EM algo-
rithm also involves the update rules for cluster factors and
covariance matrices
πj =
1
N
N  
i=1
zij,
Cj =
 N
i=1zij
 
xn(i) −aj
  
xn(i) −aj
 T
 N
i=1zij
(12)
for j = f,s, p. The E step involves assigning to the clusters,
probabilistically, contributions from the data points and the
M step involves re-estimating the parameters of the clusters
inthelightofthisassignment.Thealgorithmcyclesbackand
forth until the joint likelihood function is maximized.
When there are multiple compartment mixture regions,
one remaining issue in pixel TAC clustering is the model
selection that refers to the detection of cluster number K0.
The EM model ﬁtting cannot be used to estimate K0 since
the ML is a nondecreasing function of K0, thereby making it
useless as a model selection criterion. This problem can be,
fortunately, solved by using MDL criterion in conjunction
with EM clustering. MDL is a proven information-theoretic
criterion for model selection and has proven asymptotically
consistent. The major thrust of MDL-based cluster valida-
tion has been the formulation of a model ﬁtting procedure
in which an optimal model is selected from the several com-
peting candidates such that the selected model best ﬁts the
observed data. Speciﬁcally, the optimal value of K0 is selected
by minimizing
MDL
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=−
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πkg
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+
6K0 −1
2
logN,
(13)
where the ﬁrst term on the right is the approximation er-
ror and the second term on the right is the estimation er-
ror whose role is to penalize large value of K0.F o rK0 =
Kmin,...,Kmax,thevaluesofMDLarecalculatedandamodel
with K0 clusters is selected that will correspond to the mini-
mum MDL value.
3. EXPERIMENT AND RESULTS
In this section, we ﬁrst demonstrate the performance of clus-
tered component analysis when applied to real DCE-MRI
data sets. The data was acquired at the NIH Clinical Cen-
ter using gadolinium DTPA as the contrast agent. The three-
dimensional DCE-MRI scans were performed every 30 sec-
onds for a total of 11 minutes after the injection. For the
purpose of comparison, Figure 3 shows the estimated TACs
associated with the input function as well as the fast and slow
ﬂows obtained by the advanced parametric compartment
modeling method. The corresponding reconstructed APDs
are given in Figure 4. This represents an advanced breast tu-
mor case where active angiogenesis occurs often in the pe-
ripheral area (i.e., boundary with fast ﬂow), while the inner
core reﬂects hypoxia (dominated by slow ﬂow) [2, 3].
We then apply CCA to the same data set. The DCE-
MRI sequence contains a total of 18 images taken at diﬀer-
ent times, of which, we remove the ﬁrst few images that do
not show suﬃcient contrast accumulation and use the re-
maining 12–15 images in the experiment. After an analysis
by VISDA, MDL criterion determines that there is clearly
more than one pixel TAC cluster. By targeting the two ma-
jor compartment sources, the corresponding source TACs
are estimated and the hidden APD images are subsequently
reconstructed. Figure 5 shows the extracted source images
(i.e., vascular permeability) carrying out fast and slow dif-
fusions. The projected distribution of pixel TACs clearly re-Yue Wang et al. 5
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Figure 4: The reconstructed source factor images associated with fast and slow diﬀusions as well as plasma input.
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Figure 5: (b) shows the projected distribution of pixel TAC vectors (the dot plot represented in (b) is the two-dimensional projection of
the component TAC clusters) whose two centers correspond to the fast and slow source TACs, respectively (the associated/extracted source
images are given in (a) and (c)). (d) shows the kinetics of source TACs displayed as the time-course patterns and (e) shows the scatter plot of
the source images showing the correlation patterns.
veals a multicluster data structure, and the scatter plot of the
source images shows the expected globally negative corre-
lation dependence.In addition, the ability of estimating the
input function has aprofound impact in multivariate quan-
tiﬁcations, since otherwise blood samples will be taken inva-
sively at the radial artery or from an arterialized vein which,
however, poses health risks and is not compatible with clin-
ical practice. The outcome of CCA on further decomposing6 International Journal of Biomedical Imaging
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Figure 6: Compartmental latent variable modeling by CCA including plasma input. The source images are given in the right column (from
top to bottom: fast ﬂow, slow ﬂow, and plasma input).
the mixture into the three underlying compartments is given
in Figure 6 that presents a very consistent result with the one
obtained by the independent method based on the compart-
ment modeling shown in Figures 3 and 4. To test the stability
of the performance by CCA, we have applied this method
to a series of realistically simulated data sets in which vari-
ous realistic TACs are numerically synthesized and the mixed
observations are generated by weighting the real APDs (e.g.,
g i v e ni nF i g u r e s4 and 6) by these synthesized TACs. The re-
sults show that CCA can successfully reconstruct the hidden
clustered components under various mixtures and TAC con-
ditions.
Asanexampleofmorechallengingproblems,withsignif-
icant practical utility, we report the preliminary application
of CCA method in a longitudinal study to monitor a breast
tumor’s response to anti-angiogenic therapy. Defective en-
dothelial barrier function due to vascular endothelial growth
factor (VEGF) expression is one of the best-documented ab-
normalities of tumor vessels, resulting in spatially heteroge-
neous high microvascular permeability to macromolecules.
Initial results suggest that changes in vascular permeability
and volume fraction can be detected in a responsive tumor
soon after therapy begins. Vascular permeability has been
reported to correlate closely with VEGF expression in tu-
mors, and decrease signiﬁcantly after anti-VEGF antibody
treatment and after the administration of other inhibitors of
VEGF signaling. In breast and cervical cancers, a decrease in
transendothelial permeability often accompanies tumor’s re-
sponse to chemotherapy and an early increase or no change
in permeability can predict non-responsiveness or poorer
prognosis.
Three sets of DCE-MRI data were acquired before and
during the treatment period, each with three-months apart.
Figure 7 shows the DCE-MRI images as a potential endpoint
in assessing the response to therapy. The introduction of
imaging cancer therapies by DCE-MRI has posed new chal-
lenges to traditional anatomic imaging approaches, because
the vascularity of a tumor can change without a correspond-
ing change in tumor size and vice versa. Our preliminary
experiment shows promising results on the application of
CCAtothisproblem,seeFigure 8.Forexample,theextracted
source TACs closely resemble the expected compartmental
kinetics of the contrast agent, and both the APD images
and TACs show the expected changes of the patterns over
time, consistent with clinical assessment of a responsive case.
Of particular scientiﬁc value, our results show that tumor-
induced vascular activities were signiﬁcantly reduced after
a positive response to anti-angiogenesis chemotherapy, de-
spite a noticeable increase in tumor volume during the initial
treatment period.
4. DISCUSSION AND FUTURE WORK
In CCA approach, the signiﬁcant overlap between the source
image boundaries in space causes a potential partial volume
eﬀect (PVE) [16]. It can be shown that PVE will lead to a bi-
ased estimation of the compartment TACs. We can incorpo-
rate such PVE into the SFNM model that can be, fortunately,
estimated by a constrained EM algorithm [16]. Speciﬁcally,
we will ﬁrst apply MDL criterion (13) to estimate the most
appropriate number of distinctive temporal clusters that will
also include the so-called composite boundary clusters [16];
we will then estimate the PVE-SFNM model by only updat-
ingtheparametersofpure-volumeclustersusingzij,followed
by the assignment of the parameter values for the partial vol-
ume clusters based on the PVE model [16]. Alternatively, we
cansimplyconsiderthosecompositeboundaryclustersasin-
trinsic compartment TACs where the emphasis will be onYue Wang et al. 7
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Figure 7: DCE-MRI as a potential endpoint in monitoring tumor’s response to anti-angiogenic therapy. Three sets of DCE-MRI data of the
same tumor were acquired and are shown in (a). The tumor sites were extracted via advanced image segmentation tools and are highlighted
in (b). The pattern changes are consistent with the clinical foundings that, even as a responsive case, most tumors’ volume will grow initially
but shrink lately with much reduced vascular activities.
interpreting such compartments in relation to biological or
clinical parameters.
Inlongitudinalstudies,specialcareshouldbetakeninas-
sessingtheresponsetotherapy.Inourpresentexperiment,we
have considered longitudinal samplings separately and per-
formed blind source separation for each of the samplings. It
would be more meaningful to consider the estimated TAC
before the therapy starts as a baseline reference, and then
estimate the source images in the follow-up studies to see
whether the spatial distribution of fast and slow permeabil-
ities changes. We can also use the estimated baseline source
image as the reference, and subsequently recover the TACs in
the follow-up studies to detect the changes of diﬀusion rates.
The multivariate quantiﬁcations that reﬂect the eﬃcacy of
angiogenesis inhibitors has great potential but is at an early
stage.Partofthechallengestemsfromincompleteknowledge
of how blood vessels are aﬀected. For example, angiogenesis
inhibitorscanblockthegrowthofnewbloodvesselsfromex-
isting vessels, but may also eliminate certain existing vessels,
such as tumor vessels.
We believe that our comparative studies provide use-
ful information on the utility of the proposed methods
for computed simultaneous imaging of multiple functional
or molecular biomarkers. Given the diﬃculty of the task,
while the optimality of these methods may be data or
modality dependent, we wouldexpect them to be important
toolsin dynamic image formation and analysis. For exam-
ple, since angiogenesis is complex process critical to growth
and metastasis of malignant tumors, the clinical value and
promise of DCE-MRI in imaging tumor angiogenesis before8 International Journal of Biomedical Imaging
(a) (b) (c) (d)
Figure 8: Blind decomposition of permeability distribution and diﬀusion dynamics via CCA in a longitudinal study with three-time snap-
shots shown in Figure 7. (a) 2D projection of compartment TAC clusters and 2D projection of individual compartment TAC clusters; (b)
TACs corresponding to fast and slow ﬂows/perfusions; and (c) and (d) extracted angiogenic permeability distributions (source images) as-
sociated with fast and slow ﬂows/perfusions. Serving as the quantitative measures for monitoring functional response to therapy, the results
correspond to a positive responsive case where both fast and slow diﬀusion/perfusion rates are signiﬁcantly reduced during and after the
therapy.
and during therapy provides strong incentive for advancing
the imaging formation method [2–4]. Speciﬁcally, with the
prior information on the nonnegativity of the mixing ma-
trix and sources, new principle and perhaps improved meth-
ods may yet become possible [19]. Here we wish to propose
a nonnegative least-correlated component analysis (nLCA)
when the hidden sources and mixing matrix are known to be
nonnegative [20]. This concept has powerful features which
are of considerable universal applicability since it eliminates
the condition of source independence and non-Gaussianity
required by independent component analysis [19]. It can be
shown that when the mixing matrix is nonnegative, the cor-
relation between the mixtures is always positively increased,
namely, the correlation increase theorem [20]. Such a positive
increaseincorrelationafternonnegativemixingimmediately
suggests a possible recovering mechanism for blind source
separation of dependent sources. With the encouraging pre-
liminary success tested on real data sets, we are currently in-
vestigating the existence and uniqueness of nLCA solution
that exploits the nonnegativity constraint on correlated yet
well-grounded sources in the light of correlation increase
theorem [19, 20].
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